Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2021 Filed May 18, 2021 20:48 UTC |
SORIANO JOHNChief Compliance Officer
|
Tax withholdingCommon Stock | 1,655 | $26.23 | $43,410.65 |
DisclosureSEC source: 0001140361-21-017901 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,204 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:43 UTC |
Adsett RogerChief Commercial Officer
|
Tax withholdingCommon Stock | 2,477 | $26.23 | $64,971.71 |
DisclosureSEC source: 0001140361-21-017898 · form4.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,247 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:42 UTC |
Pellizzari Christine AChief Legal Officer
|
Tax withholdingCommon Stock | 2,546 | $26.23 | $66,781.58 |
DisclosureSEC source: 0001140361-21-017895 · form4.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,985 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:36 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Tax withholdingCommon Stock | 1,806 | $26.23 | $47,371.38 |
DisclosureSEC source: 0001140361-21-017891 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,792 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:32 UTC |
Lewis WilliamDirector · Chair and CEO
|
Tax withholdingCommon Stock | 6,481 | $26.23 | $169,996.63 |
DisclosureSEC source: 0001140361-21-017888 · form4.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,471 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:10 UTC |
Adsett RogerChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 68,640 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017469 · form4.xml · derivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,640 Underlying: Common Stock · 68,640 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:10 UTC |
Adsett RogerChief Commercial Officer
|
GrantCommon Stock | 14,172 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017469 · form4.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,724 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:07 UTC |
Bonstein SaraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 68,640 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017464 · form4.xml · derivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,640 Underlying: Common Stock · 68,640 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:07 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 14,172 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017464 · form4.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 68,640 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017462 · form4.xml · derivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,640 Underlying: Common Stock · 68,640 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 14,172 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017462 · form4.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,768 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:02 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantStock Option (right to buy) · Derivative | 137,280 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017456 · form4.xml · derivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,280 Underlying: Common Stock · 137,280 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:02 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 28,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017456 · form4.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,952 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:59 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 57,200 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017450 · form4.xml · derivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,200 Underlying: Common Stock · 57,200 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:59 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantCommon Stock | 11,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017450 · form4.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,531 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:56 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 45,760 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017444 · form4.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,760 Underlying: Common Stock · 45,760 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:56 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 9,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017444 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,598 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:54 UTC |
SORIANO JOHNChief Compliance Officer
|
GrantStock Option (right to buy) · Derivative | 34,320 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017440 · form4.xml · derivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,320 Underlying: Common Stock · 34,320 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:54 UTC |
SORIANO JOHNChief Compliance Officer
|
GrantCommon Stock | 7,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017440 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,859 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:43 UTC |
ENGELSEN STEINAR JDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017430 · form4.xml · nonDerivative · entry 1 ENGELSEN STEINAR J · CIK 0001218860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,567 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:40 UTC |
LEE LEODirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017428 · form4.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,620 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:38 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017425 · form4.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,916 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:35 UTC |
SCHAFER CAROLDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017421 · form4.xml · nonDerivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,260 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:32 UTC |
ANDERSON ELIZABETH MDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017419 · form4.xml · nonDerivative · entry 1 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,672 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:27 UTC |
Brennan David RDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017417 · form4.xml · nonDerivative · entry 1 Brennan David R · CIK 0001609305 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,876 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:24 UTC |
Desjardins ClarissaDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017415 · form4.xml · nonDerivative · entry 1 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,950 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:21 UTC |
ALTOMARI ALFREDDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017413 · form4.xml · nonDerivative · entry 1 ALTOMARI ALFRED · CIK 0001285644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,496 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 8 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,876 F5 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F6 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:22 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001140361-21-009085 · form4.xml · derivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,630 Underlying: Common Stock · 50,000 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:22 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 300 | $37.18 | $11,154.00 |
DisclosureSEC source: 0001140361-21-009085 · form4.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,608 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 300 shares sold at prices ranging from $37.05 to $37.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:22 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 26,061 | $36.66 | $955,396.26 |
DisclosureSEC source: 0001140361-21-009085 · form4.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,908 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 26,061 shares sold at prices ranging from $36.15 to $37.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:22 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 23,639 | $35.65 | $842,730.35 |
DisclosureSEC source: 0001140361-21-009085 · form4.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,969 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 23,639 shares sold at prices ranging from $35.18 to $36.13 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:22 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 50,000 | $3.40 | $170,000.00 |
DisclosureSEC source: 0001140361-21-009085 · form4.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 23,717 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · derivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,550 Underlying: Common Stock · 23,717 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC |
SORIANO JOHNChief Compliance Officer
|
SaleCommon Stock | 23,717 | $40.00 | $948,680.00 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:20 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionCommon Stock | 23,717 | $30.86 | $731,906.62 |
DisclosureSEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 12 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,267 Underlying: Common Stock · 500 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
SaleCommon Stock | 500 | $40.00 | $20,000.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 8 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionCommon Stock | 500 | $30.86 | $15,430.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 7 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,130 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 11 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,390 Underlying: Common Stock · 14,130 shares Expires 2030-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,349 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 10 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,395 Underlying: Common Stock · 17,349 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,433 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · derivative · entry 9 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,767 Underlying: Common Stock · 13,433 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
SaleCommon Stock | 14,130 | $40.38 | $570,569.40 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 6 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionCommon Stock | 14,130 | $23.75 | $335,587.50 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 5 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
SaleCommon Stock | 17,349 | $40.38 | $700,552.62 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 4 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionCommon Stock | 17,349 | $13.91 | $241,324.59 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 3 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
SaleCommon Stock | 13,433 | $40.38 | $542,424.54 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:12 UTC |
SORIANO JOHNChief Compliance Officer
|
Exercise / conversionCommon Stock | 13,433 | $30.86 | $414,542.38 |
DisclosureSEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,709 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,791 Underlying: Common Stock · 4,709 shares Expires 2024-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Tax withholdingCommon Stock | 2,479 | $38.92 | $96,482.68 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,150 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.